ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0409

Exploring Urea Clearance Measurement in a Wearable Sorbent-Based Peritoneal Dialysis (PD) Device

Session Information

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

  • Jain, Arsh, London Health Sciences Centre, London, Ontario, Canada
  • Htay, Htay, Singapore General Hospital, Singapore, Singapore
  • Brown, Edwina A., Imperial College London, London, England, United Kingdom
  • Schreiber, Martin J., Cleveland Clinic, Cleveland, Ohio, United States
  • Gow, Sheena, Vivance, Singapore, Singapore
  • Lim, Jason Tze Chern, Vivance, Singapore, Singapore
  • Singh, Sanjay, Vivance, Singapore, Singapore
  • Gori, Mandar, Vivance Inc, Los Angeles, California, United States
  • Foo, Marjorie Wai Yin, Singapore General Hospital, Singapore, Singapore
Background

In recent times, evaluating dialysis adequacy has shifted from a single solute target, i.e. Kt/Vurea, to a more holistic assessment of patients. However, some jurisdictions still mandate Kt/Vurea targets for reimbursement purposes.

Methods

Viva Kompact (VK) is a wearable, sorbent-based PD device. It regenerates 250mL of dialysate at a flow rate of 2L/hr over 56 cycles. The urea removal process in the sorbent during regeneration of dialysate makes it challenging to accurately assess solute removal, making standard PD Kt/Vurea formula of drained dialysate non-representative of the actual dialysis dose delivered. During the pre-pivotal study, VK clearance dynamics was explored – multiple outflow (leaving peritoneum) and inflow samples were taken at Cycle 4, 8, 40 and 54. These were done during full day training sessions and the first day of the 7-day Treatment period.

Results

12 subjects’ data were analysed; 10 male, dialysis vintage: 7-94 months, transport status: 1 High, 7 High A., 3 Low A., 1 Low and 1 anuric. Figure 1 shows urea levels throughout 7 hours of tidal therapy of 50 therapies, averaged across each subject; outflow urea during tidal therapy were lower than in final drain, supporting the notion that using final drain urea in the Kt/Vurea formula would not be representative of tidal clearance. During inflow, urea was mostly at undetected levels(<0.8mmol/L). As such, to cater for differences, it was proposed that tidal clearance be calculated separately from final drain clearance with a modified formula (Figure 2):

Conclusion

This study highlights the need of a modified Kt/Vurea formula for sorbent-based dialysis. While it is still used as a measure of PD efficacy, the quality of PD should be approached holistically, without relying only on small-solute clearances.

Figure 1

Figure 2

Funding

  • Commercial Support – Vivance Pte Ltd

Digital Object Identifier (DOI)